Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Korean Post-marketing Surveillance for Prevenar 20

NCT06760208 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06760208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06760208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Korean Post-marketing Surveillance for Prevenar 20
Lead sponsor
Pfizer
Phase
Observational
Overall status
Recruiting
Start date
November 13, 2025
Completion date
March 1, 2027
Enrollment
660 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal immunization, safety